Page 233 - 2020_02-Haematologica-web

Desialylation of MM overcomes bortezomib resistance in vivo
2012;1253:16-36.
27. Macauley MS, Arlian BM, Rillahan CD, et
al. Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases. J Biol Chem. 2014;289(51):35149-35158.
28. Schmidmaier R, Baumann P, Meinhardt G. Cell-cell contact mediated signalling - no fear of contact. Exp Oncol. 2006;28(1):12-15.
29. Berlin C, Berg EL, Briskin MJ, et al. Alpha 4 beta 7 integrin mediates lymphocyte bind- ing to the mucosal vascular addressin MAdCAM-1. Cell. 1993;74(1):185-195.
30. Elices MJ, Osborn L, Takada Y, et al. VCAM- 1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site dis- tinct from the VLA-4/fibronectin binding site. Cell. 1990;60(4):577-584.
31. Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989;59(6):1203-1211.
32. Bull C, Boltje TJ, Wassink M, et al. Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhe- sion, migration, and in vivo tumor growth. Mol Cancer Ther. 2013; 12(10):1935-1946.
33. Bull C, Boltje TJ, van Dinther EA, et al. Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread. ACS Nano. 2015; 9(1):733-745.
34. Swami A, Reagan MR, Basto P, et al. Engineered nanomedicine for myeloma and bone microenvironment targeting. Proc Natl Acad Sci U S A. 2014;111(28):10287-10292.
35. Bull C, Boltje TJ, Balneger N, et al. Sialic acid blockade suppresses tumor growth by enhancing T-cell-mediated tumor immunity.
Cancer Res. 2018;78(13):3574-3588.
36. Roecklein BA, Torok-Storb B. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood.
mediated regulation of multiple myeloma cell adhesion, migration, and invasion. Blood. 2011;117(23):6202-6213.
44. Tatsumi T, Shimazaki C, Goto H, et al. Expression of adhesion molecules on myelo- ma cells. Jpn J Cancer Res. 1996; 87(8):837-
1995;85(4):997-1005.
37. Zhu D, Wang Z, Zhao JJ, et al. The 842.
Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat Med. 2015;21(6):572- 580.
38. Yanamandra N, Colaco NM, Parquet NA, et al. Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia. Clin Cancer Res. 2006;12(2):591-599.
39. Farrell ML, Reagan MR. Soluble and cell-cell- mediated drivers of proteasome inhibitor resistance in multiple myeloma. Front Endocrinol (Lausanne). 2018;9(218):1-7.
40. Abdi J, Chen G, Chang H. Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms. Oncotarget. 2013;4(12):2186-2207.
41. Kim I, Uchiyama H, Chauhan D, Anderson KC. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines. Br J Haematol. 1994;87(3):483-493.
45. Streeter PR, Berg EL, Rouse BT, Bargatze RF, Butcher EC. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature. 1988;331(6151):41-46.
46. Murakami JL, Xu B, Franco CB, et al. Evidence that beta7 integrin regulates hematopoietic stem cell homing and engraftment through interaction with MAdCAM-1. Stem Cells Dev. 2016; 25(1):18-26.
47. Katayama Y, Hidalgo A, Peired A, Frenette PS. Integrin alpha4beta7 and its counter- receptor MAdCAM-1 contribute to hematopoietic progenitor recruitment into bone marrow following transplantation. Blood. 2004;104(7):2020-2026.
48. Tada T, Inoue N, Widayati DT, Fukuta K. Role of MAdCAM-1 and its ligand on the homing of transplanted hematopoietic cells in irradiated mice. Exp Anim. 2008; 57(4):347-356.
49. Masellis-Smith A, Belch AR, Mant MJ, Pilarski LM. Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: a requirement for CD44 and alpha4beta7. Cancer Res. 1997;57(5):930-
42. Luque R, Brieva JA, Moreno A, et al. Normal
and clonal B lineage cells can be distin-
guished by their differential expression of B
cell antigens and adhesion molecules in 936.
peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical impli- cations. Clin Exp Immunol. 1998;112(3):410- 418.
43. Neri P, Ren L, Azab AK, et al. Integrin beta7-
50. Finger EB, Puri KD, Alon R, Lawrence MB, von Andrian UH, Springer TA. Adhesion through L-selectin requires a threshold hydrodynamic shear. Nature. 1996; 379(6562):266-269.
haematologica | 2020; 105(2)
467